What’s Going On With Healthcare Insurance Giant Cigna Stock Today?
Cigna Group (NYSE: CI) and Humana Inc (NYSE: HUM) are reportedly discussing a merger deal to create a new powerhouse in the health insurance industry.
Citigroup Eyes New Private Credit Strategy Next Year: Report
Citigroup Inc (NYSE: C) is reportedly poised to venture into direct lending, aiming to debut this new strategy by early January, reflecting a broader trend among banks seeking to tap into the burgeoning $1.6 trillion private credit market.
Sam Altman In Discussions About OpenAI Return As Employees Revolt And MSFT Picks Up The Pieces
There were threats from the OpenAI staff of mass resignations if Sam Altman was not reinstated.
Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm.
Major Buyout Firms Eye Sanofi’s Consumer Health Division Spinoff Valued Over $20B
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over $20 billion.
Novo Nordisk Seeks Obesity, Diabetes ‘Bolt-On’ Deals As It Beefs Up Capacity To Meet Soaring Demand
Novo Nordisk A/S (NYSE: NVO) plans to invest more than DKK 42 billion
Healthcare Insurance Giant Cigna Mulls Offloading Medicare Advantage Business
Cigna Corporation (NYSE: CI) is reportedly contemplating the sale of its Medicare Advantage business and working with an investment bank to explore options for a business that could be worth billio
Apple’s New Global Play: iPhone 17 Production To Start In India, Not China, Says Top Analyst
This story was first published on the Benzinga India portal.
Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics
Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one major pharmaceutical company in recent months.
TC Energy Explores Asset Sales Worth $10B, Debt Reduction on the Horizon
Pipeline and transportation company TC Energy Corp (NYSE: TRP) is reportedly exploring selling a minority stake in ANR Pipeline Co for an estimated enterprise value of around $3 billion.